Star Scientific, Inc. (NASDAQ:STSI) utilizing alkaloids

Boston, MA 04/05/2013 (wallstreetpr) – Star Scientific, Inc. (NASDAQ:STSI)  is a technology-oriented company, with a view to promote healthy metabolism and lifestyle in the world of fast foods. More recently the company has been concentrating on the anti-inflammatory aspect of one of the alkaloids, anatabine. According to the sources of the company, the research and development efforts on the anatabine alkaloid have positioned them to utilize the technology, and develop a range of non-nicotine dietary supplements and pot related pharmaceutical products with market potentials that could usher in a healthy metabolism and in supporting good nutrition.

Currently trading at $1.37, down by 9.93%. With a total market trade volume of around $251M, the shares of STSI are regularly traded on the stock exchange. A study of the last year’s quoted stocks reveals that the price ranged between $1.26 to as high as $5.05, with an average daily trading of 1.8M shares.

With the growing concern for healthier food supplements, the market is rapidly expanding, unlike before, and Star Scientific is taking full advantage of this fact not only in the United States, but also the globe. The company aims at expanding its horizons soon. And, this is quite evident from the sell-buy analysis of its stocks on NASDAQ for the last several months.

As the research and analysis wing of the company revolves around introducing dietary supplements, which helps to promote “quit smoking”, the market acceptability of their stock has increased to a considerable extent. Exclusive rights on production of low-TSNA dissolvable smokeless tobacco products along with  the use of certain MAO agents in treating neurological conditions have given Star Scientific an edge over its competitors. It may safely be concluded that Star Scientific Inc. has made a firm position on the NASDAQ platform

For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.